Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charise Gleason

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of the Advanced Practitioner in Oncology|June 22, 2018
New Treatment Strategies Making an Impact in Multiple MyelomaCharise Gleason, Jonathan Kaufman
Blood|May 17, 2014
Down to the bitter endSagar Lonial, Charise Gleason
Seminars in Oncology Nursing|July 29, 2017
Immunotherapy in Multiple MyelomaCharise Gleason, Donna D Catamero
Current Hematologic Malignancy Reports|April 29, 2010
Treatment of relapsed and refractory myelomaJonathan Kaufman, Charise Gleason, Sagar Lonial
Current Hematologic Malignancy Reports|May 8, 2010
Improving induction therapy in multiple myelomaAjay Nooka, Charise Gleason, Sagar Lonial
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
Supportive therapies in multiple myelomaCharise Gleason, Ajay Nooka, Sagar Lonial
Biologics : Targets & Therapy|February 7, 2013
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomibAjay Nooka, Charise Gleason, Daniela Casbourne, et al.
Journal of the Advanced Practitioner in Oncology|April 13, 2026
A Comprehensive Review of Monoclonal Gammopathy of Undetermined SignificanceKimberly Noonan, Kevin Brigle, Charise Gleason, et al.
Journal of Medical Case Reports|August 16, 2011
Treatment of severe neutropenia with high-dose pyridoxine in a patient with chronic graft versus host disease and squamous cell carcinoma: a case reportMariam Rauf, Charise Gleason, Ajay K Nooka, et al.
Future Oncology (London, England)|August 24, 2018
Daratumumab and its use in the treatment of relapsed and/or refractory multiple myelomaSarah Chehab, Elyse Hall Panjic, Charise Gleason, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of the Advanced Practitioner in Oncology|June 22, 2018
New Treatment Strategies Making an Impact in Multiple MyelomaCharise Gleason, Jonathan Kaufman
Blood|May 17, 2014
Down to the bitter endSagar Lonial, Charise Gleason
Seminars in Oncology Nursing|July 29, 2017
Immunotherapy in Multiple MyelomaCharise Gleason, Donna D Catamero
Current Hematologic Malignancy Reports|April 29, 2010
Treatment of relapsed and refractory myelomaJonathan Kaufman, Charise Gleason, Sagar Lonial
Current Hematologic Malignancy Reports|May 8, 2010
Improving induction therapy in multiple myelomaAjay Nooka, Charise Gleason, Sagar Lonial
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
Supportive therapies in multiple myelomaCharise Gleason, Ajay Nooka, Sagar Lonial
Biologics : Targets & Therapy|February 7, 2013
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomibAjay Nooka, Charise Gleason, Daniela Casbourne, et al.
Journal of the Advanced Practitioner in Oncology|April 13, 2026
A Comprehensive Review of Monoclonal Gammopathy of Undetermined SignificanceKimberly Noonan, Kevin Brigle, Charise Gleason, et al.
Journal of Medical Case Reports|August 16, 2011
Treatment of severe neutropenia with high-dose pyridoxine in a patient with chronic graft versus host disease and squamous cell carcinoma: a case reportMariam Rauf, Charise Gleason, Ajay K Nooka, et al.
Future Oncology (London, England)|August 24, 2018
Daratumumab and its use in the treatment of relapsed and/or refractory multiple myelomaSarah Chehab, Elyse Hall Panjic, Charise Gleason, et al.
Pageof 3